Zydus Lifesciences Ltd
NSE:ZYDUSLIFE

Watchlist Manager
Zydus Lifesciences Ltd Logo
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Watchlist
Price: 923.6 INR 0.39% Market Closed
Market Cap: 929.4B INR

Zydus Lifesciences Ltd
Retained Earnings

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Zydus Lifesciences Ltd
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Retained Earnings
₹252B
CAGR 3-Years
15%
CAGR 5-Years
17%
CAGR 10-Years
18%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Retained Earnings
₹359.3B
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Retained Earnings
₹327.6B
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
11%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Retained Earnings
₹775.8B
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
11%
Lupin Ltd
NSE:LUPIN
Retained Earnings
₹159.8B
CAGR 3-Years
11%
CAGR 5-Years
5%
CAGR 10-Years
5%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Retained Earnings
₹82.8B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
10%
No Stocks Found

Zydus Lifesciences Ltd
Glance View

Zydus Lifesciences Ltd., a resilient player in India's pharmaceutical industry, traces its origins back to 1952, when it was founded in Ahmedabad. Over the decades, it has metamorphosed from a modest venture into a global healthcare presence, with a diverse repertoire that spans across pharmaceuticals, animal health, and consumer wellness products. The company's ethos is deeply embedded in innovation, steadfastly pursuing research and development to propel its pipeline of generics, novel therapeutics, and vaccines. With a robust manufacturing infrastructure spread across continents, Zydus ensures seamless distribution and availability of its products, thereby maintaining a key foothold in both established and emerging markets. The lifeblood of Zydus's profitability streams from its comprehensive product portfolio, catering to a myriad of therapeutic areas such as cardiology, gastroenterology, and women's health, among others. It generates revenue primarily through the sale of branded generics and active pharmaceutical ingredients (APIs). Strategic alliances and collaborations further bolster its growth trajectory, providing new avenues for market expansion and technological advancements. As the firm continues to navigate the complex landscape of global healthcare demands, it remains anchored to its core mission of delivering accessible and affordable healthcare solutions, ensuring that it not only sustains its economic pulse but also positively impacts countless lives worldwide.

ZYDUSLIFE Intrinsic Value
812.98 INR
Overvaluation 12%
Intrinsic Value
Price

See Also

What is Zydus Lifesciences Ltd's Retained Earnings?
Retained Earnings
252B INR

Based on the financial report for Sep 30, 2025, Zydus Lifesciences Ltd's Retained Earnings amounts to 252B INR.

What is Zydus Lifesciences Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
18%

Over the last year, the Retained Earnings growth was 16%. The average annual Retained Earnings growth rates for Zydus Lifesciences Ltd have been 15% over the past three years , 17% over the past five years , and 18% over the past ten years .

Back to Top